Screener
Cogent Biosciences, Inc. COGT Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Series A non-voting convertible preferred stock, $0.001 par value; 1,000,000 shares authorized; 39,414 and 67,414 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 29,190 | 53,830 |
| Series B non-voting convertible preferred stock, $0.001 par value; 20,580 shares authorized; 4,516 shares issued and outstanding at March 31, 2026 and December 31, 2025 | 35,563 | 35,563 |
| Common stock, $0.001 par value; 300,000,000 shares authorized; 170,773,803 and 160,980,024 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 171 | 161 |
| Additional paid-in capital | 1,828,956 | 1,734,882 |
| Accumulated other comprehensive income (loss) | (415) | 355 |
| Accumulated deficit | (1,285,772) | (1,188,420) |
| Total stockholders’ equity | 607,693 | 636,371 |
| Total liabilities and stockholders’ equity | $903,006 | $937,607 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cogent Biosciences, Inc.'s total liabilities & equity?
- Cogent Biosciences, Inc. (COGT) reported total liabilities & equity of $903.01M in Q1 2026.
- How has Cogent Biosciences, Inc.'s total liabilities & equity changed year-over-year?
- Cogent Biosciences, Inc.'s total liabilities & equity increased by 218.2% year-over-year, from $283.8M to $903.01M.
- What is the long-term trend for Cogent Biosciences, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s total liabilities & equity has grown at a 30.2% compound annual growth rate (CAGR), from $250.92M to $937.61M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Cogent Biosciences, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude